Healthcare providers are looking to medical devices to play a new role in hospital care, providing a whole-patient view of health through technologies that talk to each other and help clinicians make decisions about treatment.
Device Talks Podcasts
Each week, the DeviceTalks podcast will bring the energy and insights of our medtech events to you via iTunes, Spotify and other podcasts channels. Hosted by our DeviceTalks editorial director Tom Salemi, the DeviceTalks podcast will tell the stories of the entrepreneurs, executives and other leaders who have committed their careers to making medtech better.
The Host:
DeviceTalks editorial director Tom Salemi brings over two decades of medtech writing to each episode of DeviceTalks. Prior to joining WTWH Media, Tom organized conferences, wrote feature articles, broke news and hosted an influential podcast. Tom grew up outside of Boston, so he’s thrilled to be organizing this region’s most influential medtech meeting. Tom lives north of Boston with his wife, two sons, and Daisy the Dog.
Podcast: Conquering venous disease with Veniti founder and chief Sean Morris
Veniti founder, president & CEO Sean Morris is on the march, looking to take over venous disease treatment with a suit of specialized devices that he hopes will knock out their more generic forebears.
Veniti, formed in 2009, specializes in devices for the venous anatomy, an arena often covered in a larger medical device company’s vascular devices business.
Podcast: Rep. Owens on repealing the med-tech tax
MassDevice.com Podcast: ConforMis CEO Philipp Lang
Philipp Lang has ConforMIS looking to get a leg up on the knee replacement industry.
Last week, the Burlington, Mass.-based orthopedic implant maker said it raised $89 million in a Series E round from several investors, bringing the total nut raised by ConforMIS over the last 3 years to more than $140 million – a somewhat remarkable amount, given the fundraising climate over the past few years.
MassDevice Podcast: Soteira CEO Larry Jasinski
MassDevice Podcast: Tackling paralysis with Alfred Mann Foundation CEO David Hankin
Medtronic CEO nixes spine spinout, BSX COO to step down, Podcast with Capsule Tech CEO | MassDevice.com +3
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this Halloween, make sure you’re still in the know with MassDevice +3.
MassDevice Podcast: Capsule Tech’s Stuart Long talks connectivity, innovation and momentum
MassDevice Podcast: AccuVein CEO Ron Goldman
Venipuncture – drawing blood or establishing an intravenous feed – is the most common invasive medical procedure. For many patients, it’s a painful exercise in frustration when clinicians struggle to find a blood vessel, sometimes requiring multiple needle sticks.
AccuVein and CEO Ron Goldman aim to change all that with the company’s AV300 vascular illumination device. The wireless, handheld module uses a pair of lasers to paint a patient’s arm with light, making otherwise invisible or hard-to-find blood vessels apparent to the naked eye.
MassDevice Podcast: Mela Sciences’ CEO on the MelaFind odyssey
MassDevice Podcast: Neuronetics CEO Bruce Shook
Neuronetics’ NeuroStar TMS therapy system
Neuronetics Inc. is paving the way for a new type of depression therapy, a non-invasive electromagnetic field treatment designed to stimulate brain cells linked to depression.
Bruce Shook, co-founder, president & CEO, talked to MassDevice about pioneering the market for the only FDA-cleared transcranial magnetic stimulation system to date, his company’s NeuroStar TMS system.
The therapy, which won the FDA nod in 2008, is a rarity in the med-tech world: A device-based approach to a psychiatric disorder.